Online ISSN: 1884-4111 Print ISSN: 0033-8303
Radioisotopes 73(2): 139-145 (2024)

解説Short Review

疾患や標的分子の特性に応じて精密設計した放射性薬剤の開発Development of the Precision-designed Radiopharmaceuticals Depending on the Targeting Molecules

金沢大学医薬保健研究域薬学系Kanazawa University

発行日:2024年7月15日Published: July 15, 2024


Nuclear medicine diagnosis is an in vivo imaging technique that employs radiopharmaceuticals in which diagnostic radionuclides are introduced. This technique facilitates the chronological diagnosis of various diseases and elucidates the pathological mechanisms. Radiopharmaceuticals featuring therapeutic radionuclides are anticipated to surve as a novel cancer therapy due to their potent cytotoxic effects on lesions throughout the body. This review focuses on recent research trends in the development of radiopharmaceuticals for nuclear medicine diagnosis and therapy for cancer and brain diseases, including our studies.

Key words: nuclear medicine diagnosis; radionuclide therapy; radiopharmaceuticals; radiotheranostics

This page was created on 2024-02-09T13:51:01.053+09:00
This page was last modified on 2024-04-08T13:53:08.000+09:00